ArticlePloS one2025
Factors associated with prolonged viral shedding in COVID-19 infection: A retrospective cohort from Karachi, Pakistan.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe implications of prolonged viral shedding in COVID-19 are of major public health concern. There are several studies elucidating the impact on transmission; there is a lack of data on outcomes. The objective of this study was to identify factors associated with prolonged viral shedding and its impact on disease outcomes in COVID-19.
methodsThis retrospective cohort was conducted on hospitalized throat swab-PCR confirmed COVID-19 patients admitted between March 01, 2020, and June 07, 2020, at the Aga Khan University Hospital in Karachi, Pakistan. Demographic, treatment and successive SARS CoV-2 PCR data were extracted from medical records using a structured proforma. Prolonged viral shedding was defined as PCR positivity greater than or equal to 15 days from the first positive PCR. Outcomes studied included in-hospital mortality, length of stay, and requirement of mechanical ventilation.
resultsOut of 435 patients, only 110 could be assessed for time to negativity. 47 patients (42.7%) had viral shedding for more than 15 days compared to 63 (57.3%) patients with viral shedding for less than 15 days. The median duration of time to negativity in the prolonged shedding group was 25 days compared to 9 days in the other group. The median age was 54, and it was similar in both groups. Most of the patients had mild diseases in both groups. There was no statistically significant difference between either of the groups in terms of in-hospital mortality (2/47 versus 1/63) and length of stay (9 versus 8) days.
conclusionThis study did not find any factors associated with prolonged viral shedding in COVID-19, and there was no impact of prolonged viral shedding on in-hospital mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.